연구성과로 돌아가기
2025 연구성과별 연구자 정보 (360 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study | Zhu, Chong | Zhu, C | 9 | Brii Biosci Beijing Co Ltd, Beijing, Peoples R China | jia_jd@ccmu.edu.cn; | |||||
| Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study | Wu, Yue | Wu, Y | 10 | Brii Biosci Beijing Co Ltd, Beijing, Peoples R China | jia_jd@ccmu.edu.cn; | |||||
| Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study | Chen, Xiaofei | Chen, XF | 11 | Brii Biosci Beijing Co Ltd, Beijing, Peoples R China | jia_jd@ccmu.edu.cn; | |||||
| Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study | Margolis, David | Margolis, D | 12 | Brii Biosci Inc, Durham, USA | jia_jd@ccmu.edu.cn; | |||||
| Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study | Zhu, Qing | Zhu, Q | 13 | Brii Biosci Inc, Durham, USA | jia_jd@ccmu.edu.cn; | |||||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Jun, Jae-Bum | Jun, JB | 1 | Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul, South Korea | drsong@cau.ac.kr; | |||||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Lee, Hye-Soon | Lee, HS | 2 | Hanyang Univ, Guri Hosp, Dept Internal Med, Div Rheumatol,Coll Med, Guri, South Korea | drsong@cau.ac.kr; | |||||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Kim, Sang-Hyon | Kim, SH | 3 | Keimyung Univ, Coll Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea | drsong@cau.ac.kr; | |||||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Lee, Seung-Geun | Lee, SG | 4 | Pusan Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Busan, South Korea | drsong@cau.ac.kr; | |||||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Lim, Doo-Ho | Lim, DH | 5 | Univ Ulsan, Coll Med, Ulsan Univ Hosp, Div Rheumatol,Dept Internal Med, Ulsan, South Korea | drsong@cau.ac.kr; | |||||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Kim, Jinhyun | Kim, J | 6 | Chungnam Natl Univ, Coll Med, Dept Internal Med, Div Rheumatol, Daejeon, South Korea | drsong@cau.ac.kr; | |||||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Park, Yong-Beom | Park, YB | 7 | Yonsei Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea | IVH-2192-2023 | Park, Yong-Beom | drsong@cau.ac.kr; | |||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Lim, Mie Jin | Lim, MJ | 8 | Inha Univ, Dept Internal Med, Div Rheumatol, Incheon, South Korea | drsong@cau.ac.kr; | |||||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Hong, Seung-Jae | Hong, SJ | 9 | Kyung Hee Univ, Kyung Hee Univ Hosp, Coll Med, Dept Rheumatol, Seoul, South Korea | drsong@cau.ac.kr; | |||||
| Efficacy and safety of epaminurad, a potent hURAT1 inhibitor, in patients with gout: a randomized, placebo-controlled, dose-finding study | Choi, Hyo-Jin | Choi, HJ | 10 | Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Rheumatol, Incheon, South Korea | drsong@cau.ac.kr; |
페이지 이동: